# Percutaneous Sclerotherapy of Symptomatic Liver Hemangioma With Bleomycin

> **NCT03649113** · PHASE1 · COMPLETED · sponsor: **Tehran University of Medical Sciences** · enrollment: 25 (actual)

## Conditions studied

- Hemangioma Liver

## Interventions

- **PROCEDURE:** sclerotherapy arm

## Key facts

- **NCT ID:** NCT03649113
- **Lead sponsor:** Tehran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-01
- **Primary completion:** 2019-09-01
- **Final completion:** 2020-07-01
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2020-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03649113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03649113, "Percutaneous Sclerotherapy of Symptomatic Liver Hemangioma With Bleomycin". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03649113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*